SCHEMBL27929735

SCHEMBL27929735

O=C(/C=C/c1cccs1)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.55
▸ SMN1; SMN2 Q16637 9/20 0.55
▸ MAPT P10636 8/20 0.55
▸ ALDH1A1 P00352 6/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ MAPK1 P28482 3/20 0.55
▸ NPC1 O15118 11/20 0.55
▸ KDM4E B2RXH2 6/20 0.54
▸ TP53 P04637 2/20 0.54
▸ PSMD14 O00487 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ CASP3 P42574 2/20 0.52
▸ SENP8 Q96LD8 2/20 0.52
▸ SENP7 Q9BQF6 2/20 0.52
▸ SENP6 Q9GZR1 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ POLB P06746 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13675782 0.77 ESR1 (0.63) RAB9AMAPTKDM4ELMNAESR1
SCHEMBL14529039 0.77 BACE1 (0.52) MAPTESR1
SCHEMBL13675658 0.76 ESR1 (0.67) MAPTMEN1KMT2ALMNAESR1
SCHEMBL20353541 0.76 RAB9A (0.67) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL18985299 0.76 RAB9A (0.74) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL18985301 0.76 RAB9A (0.74) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL27752045 0.75 RAB9A (0.67) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL3040770 0.75 RAB9A (0.69) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL27752021 0.75 RAB9A (0.67) RAB9ASMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL3040771 0.75 RAB9A (0.69) RAB9ASMN1; SMN2MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214472-A Preparation of two novel non-ATP (Adenosine Triphosphate) competitive FGFR1 (Fibroblast Growth Factor Receptor1) inhibitors and anti-tumor activity of two novel non-ATP competitive FGFR1 inhibitors WENZHOU MEDICAL COLLEGE 2013-07-24 — — CN disclosed
Send feedback